dr mercola berberine and micropqq

Popular tags

Popular on the whole site

2. Non-Reinforcing Fillers Unlike reinforcing fillers, non-reinforcing fillers typically serve to reduce costs and improve processing ease rather than enhance mechanical strength. Examples include calcium carbonate, talc, and clay. These fillers can also enhance certain properties, such as thermal conductivity or opacity, depending on the specific application.


An API is the substance in a pharmaceutical drug that is biologically active. It is the element that provides the therapeutic effect, distinguishing one medication from another. For instance, in a pain relief tablet, the API might be acetaminophen, whereas the remaining ingredients, known as excipients, help to deliver the API effectively but do not exert therapeutic effects themselves.


1. Fiber Essential for promoting healthy digestion, fiber helps facilitate bowel movements, allowing the body to eliminate waste effectively.

PYY is a redox cofactor found in various foods such as kiwi, green peppers, and fermented soy products. It has been studied for its potent antioxidant properties and its role in cellular functions. By facilitating the generation of new mitochondria — the powerhouse of cells — PQQ plays an essential role in energy metabolism. This unique action is one reason why PQQ has garnered interest in the realm of dietary supplementation.


7. Regulatory Approval and Release


1. Mineral Fillers These include talc, calcium carbonate, and clay, which improve the mechanical strength, thermal stability, and dimensional stability of plastics. For example, incorporating calcium carbonate into polypropylene can enhance its stiffness while reducing production costs.


At its core, CAAA emphasizes the collective responsibility of individuals, organizations, and governments to combat various societal challenges. The movement encourages people to come together, leveraging their unique skills and resources to create sustainable solutions. It fosters a culture of participation and inclusivity, recognizing that every voice matters in the pursuit of common goals. Through collaboration, CAAA harnesses the power of collective intelligence, enabling communities to address issues more effectively than they could independently.


Moreover, the global landscape of pharmaceutical intermediates is characterized by growing demand. The rise in chronic diseases, advancements in biotechnology, and the increasing need for personalized medicine are driving the need for more complex and diverse intermediates. As a result, companies are expanding their R&D efforts to discover new intermediates that can enhance the therapeutic profiles of existing drugs or lead to the development of entirely new classes of medications.


Popular articles

Links